Autologous patient specific tumor antigen response
IMULAN BioTherapeutics, LLC, Oncology, Immunotherapy, Experimental cancer treatment, Autotransplantation
Herausgegeben: Horst, Kristen Nehemiah
Versandkostenfrei!
Versandfertig in 6-10 Tagen
23,99 €
inkl. MwSt.
PAYBACK Punkte
12 °P sammeln!
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Autologous Patient Specific Tumor Antigen Response technology, or apSTAR, is a new cancer treatment procedure being developed by IMULAN BioTherapeutics, LLC and Veterinary Cancer Therapeutics, LLC for comparative oncology. Also known as laser-assisted immunotherapy, apSTAR is an experimental cancer treatment for solid tumors that utilizes an autologous vaccine-like approach to stimulate immune responses. Specifically, laser-assisted immunotherapy combines laser-induce...
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Autologous Patient Specific Tumor Antigen Response technology, or apSTAR, is a new cancer treatment procedure being developed by IMULAN BioTherapeutics, LLC and Veterinary Cancer Therapeutics, LLC for comparative oncology. Also known as laser-assisted immunotherapy, apSTAR is an experimental cancer treatment for solid tumors that utilizes an autologous vaccine-like approach to stimulate immune responses. Specifically, laser-assisted immunotherapy combines laser-induced in situ tumor devitalization with an immunoadjuvant for local immunostimulation.
Andere Kunden interessierten sich für
